Optimizing Management of Type 2 Diabetes and Its Complications in Patients With Heart Failure.
作者信息
Schumacher Christie A, Van Dril Elizabeth K, Shealy Kayce M, Goldman Jennifer D
机构信息
Chicago College of Pharmacy, Midwestern University, Downers Grove, IL.
College of Pharmacy, University of Illinois at Chicago, Chicago, IL.
出版信息
Clin Diabetes. 2021 Jan;39(1):105-116. doi: 10.2337/cd20-0008.
Abstract
摘要
相似文献
1
Optimizing Management of Type 2 Diabetes and Its Complications in Patients With Heart Failure.优化心力衰竭患者2型糖尿病及其并发症的管理
Clin Diabetes. 2021 Jan;39(1):105-116. doi: 10.2337/cd20-0008.
2
Metformin in patients with type 2 diabetes mellitus and heart failure: a review.二甲双胍在 2 型糖尿病合并心力衰竭患者中的应用：综述。
Endokrynol Pol. 2021;72(2):163-170. doi: 10.5603/EP.a2021.0033.
3
Improving management practices and clinical outcomes in type 2 diabetes study: Prevalence of complications in people with type 2 diabetes in India.改善2型糖尿病管理实践与临床结局研究：印度2型糖尿病患者并发症患病率
Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S430-1. doi: 10.4103/2230-8210.104119.
4
Approach to the management of diabetic patients with heart failure: role of thiazolidinediones.糖尿病合并心力衰竭患者的管理方法：噻唑烷二酮类药物的作用
Am Heart J. 2004 Oct;148(4):551-8. doi: 10.1016/j.ahj.2004.04.033.
5
Clinical and socio-demographic determinants of self-care behaviours in patients with heart failure and diabetes mellitus: A multicentre cross-sectional study.心力衰竭合并糖尿病患者自我护理行为的临床和社会人口统计学决定因素：一项多中心横断面研究。
Int J Nurs Stud. 2016 Nov;63:18-27. doi: 10.1016/j.ijnurstu.2016.08.006. Epub 2016 Aug 16.
6
The Prognostic Significance of Diabetes and Microvascular Complications in Patients With Heart Failure With Preserved Ejection Fraction.糖尿病和微血管并发症对射血分数保留的心力衰竭患者预后的意义。
Diabetes Care. 2018 Jan;41(1):150-155. doi: 10.2337/dc17-0755. Epub 2017 Oct 19.
7
Telehealth Interventions to Support Self-Management of Long-Term Conditions: A Systematic Metareview of Diabetes, Heart Failure, Asthma, Chronic Obstructive Pulmonary Disease, and Cancer.支持长期疾病自我管理的远程医疗干预措施：糖尿病、心力衰竭、哮喘、慢性阻塞性肺疾病和癌症的系统元综述
J Med Internet Res. 2017 May 17;19(5):e172. doi: 10.2196/jmir.6688.
8
[Diabetes mellitus and chronic heart failure].[糖尿病与慢性心力衰竭]
Vnitr Lek. 2003 Dec;49(12):927-34.
9
Thiazolidinediones in patients with diabetes mellitus and heart failure : implications of emerging data.噻唑烷二酮类药物用于糖尿病合并心力衰竭患者：新出现数据的意义
Am J Cardiovasc Drugs. 2006;6(5):297-304. doi: 10.2165/00129784-200606050-00002.
10
Microvascular complications in diabetes patients with heart failure and reduced ejection fraction-insights from the Beta-blocker Evaluation of Survival Trial.糖尿病合并射血分数降低心力衰竭患者的微血管并发症——来自β受体阻滞剂生存试验的观察。
Eur J Heart Fail. 2018 Nov;20(11):1549-1556. doi: 10.1002/ejhf.1201. Epub 2018 May 4.
本文引用的文献
1
9. Pharmacologic Approaches to Glycemic Treatment: .9. 血糖治疗的药物学方法： 。
Diabetes Care. 2020 Jan;43(Suppl 1):S98-S110. doi: 10.2337/dc20-S009.
2
Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis.二甲双胍的使用与 2 型糖尿病患者心力衰竭住院风险降低相关：一项回顾性队列分析。
J Am Heart Assoc. 2019 Nov 5;8(21):e011640. doi: 10.1161/JAHA.118.011640. Epub 2019 Oct 21.
3
Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial.利格列汀与格列美脲对2型糖尿病患者主要不良心血管结局的影响：卡罗来纳州随机临床试验
JAMA. 2019 Sep 24;322(12):1155-1166. doi: 10.1001/jama.2019.13772.
4
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.达格列净治疗射血分数降低的心力衰竭患者。
N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19.
5
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study.钠-葡萄糖共转运蛋白 2 抑制剂与严重尿路感染风险：一项基于人群的队列研究。
Ann Intern Med. 2019 Aug 20;171(4):248-256. doi: 10.7326/M18-3136. Epub 2019 Jul 30.
6
Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals.糖尿病是女性和男性心力衰竭的危险因素：包括 1200 万人在内的 47 项队列的系统评价和荟萃分析。
Diabetologia. 2019 Sep;62(9):1550-1560. doi: 10.1007/s00125-019-4926-x. Epub 2019 Jul 18.
7
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.度拉糖肽与 2 型糖尿病患者的心血管结局（REWIND）：一项双盲、随机、安慰剂对照试验。
Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9.
8
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.口服司美格鲁肽与 2 型糖尿病患者的心血管结局。
N Engl J Med. 2019 Aug 29;381(9):841-851. doi: 10.1056/NEJMoa1901118. Epub 2019 Jun 11.
9
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update.2 型糖尿病与心力衰竭：美国心脏协会和美国心力衰竭学会科学声明：本声明并非对 2017 年 ACC/AHA/HFSA 心力衰竭指南更新的更新。
Circulation. 2019 Aug 13;140(7):e294-e324. doi: 10.1161/CIR.0000000000000691. Epub 2019 Jun 6.
10
Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care.恩格列净在常规临床治疗中心衰住院风险的研究
Circulation. 2019 Jun 18;139(25):2822-2830. doi: 10.1161/CIRCULATIONAHA.118.039177. Epub 2019 Apr 8.
Zotero 插件